CMMB
Chemomab Therapeutics
CMMB • NASDAQ
Chemomab Therapeutics is a pharmaceutical preparations company trading on NASDAQ, led by CEO Adi Mor George.
CEOAdi Mor George
Next Earnings
Upcoming earnings announcement for Chemomab Therapeutics
Date
Thursday, May 14, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.08
Earnings History
Past 12 earnings reports for Chemomab Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 19, 2026 | Q4 2025 | -$0.24Est: -$0.10 | -140.0% | - | — | — |
| Nov 20, 2025 | Q3 2025 | -$0.28Est: -$0.10 | -180.0% | - | — | — |
| Aug 14, 2025 | Q2 2025 | -$0.09Est: -$0.09 | 0.0% | - | — | — |
| May 15, 2025 | Q1 2025 | -$0.14Est: -$0.01 | -1300.0% | - | — | — |
| Mar 3, 2025 | Q4 2024 | -$0.16Est: -$0.01 | -1500.0% | - | — | — |
| Nov 14, 2024 | Q3 2024 | -$0.20Est: -$0.01 | -1900.0% | - | — | — |
| Aug 21, 2024 | Q2 2024 | -$0.26 | — | - | — | — |
| May 9, 2024 | Q1 2024 | -$0.28 | — | - | — | — |
| Mar 7, 2024 | Q4 2023 | -$0.26 | — | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$0.34Est: -$0.02 | -1600.0% | - | — | — |
| Aug 14, 2023 | Q2 2023 | -$0.72Est: -$0.80 | +10.0% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.80Est: -$0.03 | -2566.7% | - | — |  10-Q |